Ligand Pharmaceuticals
LGND
HK$1,059
Share price
-0.67%
Change (1 day)
24.68%
Change (1 year)
Number of shares outstanding for Ligand Pharmaceuticals (LGND)
Number of shares outstanding as of July 2025 : 19,191,000
According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 19,191,000. At the end of 2025 the company had 19,191,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Ligand Pharmaceuticals from 2022 to 2025
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 19.19 M | 1.14% |
| 2024 | 18.97 M | 8.63% |
| 2023 | 17.46 M | 3.41% |
| 2022 | 16.89 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 538,000,000 | 2,703.40% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | 201,918,066 | 952.15% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,038,500,000 | 10,522.17% | 🇬🇧 UK |
 Merck MRK | 2,516,394,128 | 13,012.37% | 🇺🇸 USA |
 Pfizer PFE | 5,675,000,000 | 29,471.15% | 🇺🇸 USA |
 Eli Lilly LLY | 897,989,151 | 4,579.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,031,000,000 | 10,483.09% | 🇺🇸 USA |
 Baxter BAX | 512,000,000 | 2,567.92% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 2,405,625,000 | 12,435.17% | 🇺🇸 USA |